电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

CCL4 Protein (AA 24-92)

This Recombinant CCL4 protein is expressed in 大肠杆菌(E. Coli).
产品编号 ABIN6952197
发货至: 中国

Quick Overview for CCL4 Protein (AA 24-92) (ABIN6952197)

抗原

See all CCL4 蛋白
CCL4 (Chemokine (C-C Motif) Ligand 4 (CCL4))

蛋白类型

Recombinant

生物活性

Active

宿主

  • 8
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2

资源

  • 21
  • 5
  • 2
  • 1
大肠杆菌(E. Coli)

应用范围

Cell Migration Assay (CMA)
  • 产品特性

    AA 24-92

    序列

    APMGSDPPTA CCFSYTARKL PRNFVVDYYE TSSLCSQPAV VFQTKRSKQV CADPSESWVQ EYVYDLELN

    产品特性

    Recombinant Human CCL4 (MIP-1beta)

    内毒素水平

    <0.01 EU per 1μg of the protein by the LAL method

    Biological Activity Comment

    EC50 = 0.23 nM determined by Calcium Flux
  • 想要此Protein的其他选项吗?

    !
    探索我们的预定义定制蛋白和定制蛋白服务!

    您的项目需要进一步定制吗?联系我们,了解我们的定制蛋白解决方案

  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Spin tube prior to resuspending. Recommended at 100 μg/mL in sterile water

    储存条件

    -20 °C,-80 °C

    储存方法

    12 months from date of receipt, -20 to -70 °C as supplied.
    Suggest to use immediately after reconstitution
    1 month at -20 to -70 °C under sterile conditions after reconstitution.

    有效期

    12 months
  • 抗原

    CCL4 (Chemokine (C-C Motif) Ligand 4 (CCL4))

    别名

    CCL4 (MIP-1beta)

    背景

    Monokine with inflammatory and chemokinetic properties binds to CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant MIP-1-beta induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form MIP-1-beta (3-69) retains the abilities to induce down-modulation of surface expression of the chemokine receptor CCR5 and to inhibit the CCR5-mediated entry of HIV-1 in T-cells. MIP-1-beta(3-69) is also a ligand for CCR1 and CCR2 isoform B.

    分子量

    7.818 kDa

    UniProt

    P13236
You are here:
Chat with us!